BACKGROUND: Several studies support the dysbindin (dystrobrevin binding protein 1) gene (DTNBP1) as a susceptibility gene for schizophrenia. We previously reported that variation at a specific 3-locus haplotype influences susceptibility to schizophrenia in a large United Kingdom (UK) Caucasian case-control sample. METHODS: Using similar methodology to our schizophrenia study, we have investigated this same 3-locus haplotype in a large, well-characterized bipolar sample (726 Caucasian UK DSM-IV bipolar I patients; 1407 ethnically matched controls). RESULTS: No significant differences were found in the distribution of the 3-locus haplotype in the full sample. Within the subset of bipolar I cases with predominantly psychotic episodes of mood disturbance (n = 133) we found nominally significant support for association at this haploptype (p < .042) and at SNP rs2619538 (p = .003), with a pattern of findings similar to that in our schizophrenia sample. This finding was not significant after correction for multiple testing. CONCLUSIONS: Our data suggest that variation at the polymorphisms examined does not make a major contribution to susceptibility to bipolar disorder in general. They are consistent with the possibility that DTNBP1 influences susceptibility to a subset of bipolar disorder cases with psychosis. However, our subset sample is small and the hypothesis requires testing in independent, adequately powered samples.
BACKGROUND: Several studies support the dysbindin (dystrobrevin binding protein 1) gene (DTNBP1) as a susceptibility gene for schizophrenia. We previously reported that variation at a specific 3-locus haplotype influences susceptibility to schizophrenia in a large United Kingdom (UK) Caucasian case-control sample. METHODS: Using similar methodology to our schizophrenia study, we have investigated this same 3-locus haplotype in a large, well-characterized bipolar sample (726 Caucasian UK DSM-IV bipolar Ipatients; 1407 ethnically matched controls). RESULTS: No significant differences were found in the distribution of the 3-locus haplotype in the full sample. Within the subset of bipolar I cases with predominantly psychotic episodes of mood disturbance (n = 133) we found nominally significant support for association at this haploptype (p < .042) and at SNP rs2619538 (p = .003), with a pattern of findings similar to that in our schizophrenia sample. This finding was not significant after correction for multiple testing. CONCLUSIONS: Our data suggest that variation at the polymorphisms examined does not make a major contribution to susceptibility to bipolar disorder in general. They are consistent with the possibility that DTNBP1 influences susceptibility to a subset of bipolar disorder cases with psychosis. However, our subset sample is small and the hypothesis requires testing in independent, adequately powered samples.
Authors: Michael Elashoff; Brandon W Higgs; Robert H Yolken; Michael B Knable; Serge Weis; Maree J Webster; Beata M Barci; E Fuller Torrey Journal: J Mol Neurosci Date: 2007 Impact factor: 3.444
Authors: Hwagyu Suh; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Soo Yeon Kim; Kang Yoon Lee; Young In Chung Journal: Psychiatry Clin Neurosci Date: 2019-02-02 Impact factor: 5.188
Authors: Joanne Voisey; Christopher D Swagell; Ian P Hughes; Jason P Connor; Bruce R Lawford; Ross M Young; C Phillip Morris Journal: Behav Brain Funct Date: 2010-07-09 Impact factor: 3.759
Authors: Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan Journal: Schizophr Bull Date: 2009-04-21 Impact factor: 9.306
Authors: Rami Abou Jamra; Robert Fuerst; Radka Kaneva; Guillermo Orozco Diaz; Fabio Rivas; Fermin Mayoral; Eudoxia Gay; Sebastian Sans; Maria Jose Gonzalez; Susana Gil; Francisco Cabaleiro; Francisco Del Rio; Fermin Perez; Jesus Haro; Georg Auburger; Vihra Milanova; Christian Kostov; Vesselin Chorbov; Vessela Stoyanova; Amelia Nikolova-Hill; George Onchev; Ivo Kremensky; Assen Jablensky; Thomas G Schulze; Peter Propping; Marcella Rietschel; Markus M Nothen; Sven Cichon; Thomas F Wienker; Johannes Schumacher Journal: Am J Hum Genet Date: 2007-09-17 Impact factor: 11.025
Authors: Lingjun Zuo; Xingguang Luo; Henry R Kranzler; Lingeng Lu; Robert A Rosenheck; Joyce Cramer; Daniel P van Kammen; Joseph Erdos; Dennis S Charney; John Krystal; Joel Gelernter Journal: Psychiatr Genet Date: 2009-12 Impact factor: 2.458
Authors: Peter P Zandi; Pamela L Belmonte; Virginia L Willour; Fernando S Goes; Judith A Badner; Sylvia G Simpson; Elliot S Gershon; Francis J McMahon; J Raymond DePaulo; James B Potash Journal: Arch Gen Psychiatry Date: 2008-07